METACARE Co., Ltd.: debt-to-equity, ROE and more
KOSPI, Legal name METACARE Co., Ltd.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 63.6%
- Equity ratio
- 61.1%
- ROE
- -0.2%
- Op. margin
- 4.0%
- Rev. growth
- 62.4%
- Interest coverage
- n/a
Condition flags
- Operating profit for 2 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 47.7% | 67.7% | 6.5% | -9.6% | n/a |
| FY2022 consolidated | 46.5% | 68.3% | -38.2% | -1.6% | 2.6% |
| FY2023 consolidated | 12.8% | 88.7% | -18.9% | -16.0% | 191.9% |
| FY2024 consolidated | 35.5% | 73.8% | 7.2% | 7.4% | -63.8% |
| FY2025 consolidated | 63.6% | 61.1% | -0.2% | 4.0% | 62.4% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩18.6B | ₩19.1B | ₩55.8B | ₩20.2B | ₩32.8B |
| Operating profit | -₩1.8B | -₩300.5M | -₩8.9B | ₩1.5B | ₩1.3B |
| Pre-tax income | ₩7.5B | -₩49.6B | -₩26.2B | ₩2.7B | -₩204.9M |
| Net income | ₩7.8B | -₩49.6B | -₩26.0B | ₩8.4B | -₩211.9M |
| Total assets | ₩176.3B | ₩189.9B | ₩155.3B | ₩156.7B | ₩198.0B |
| Total liabilities | ₩56.9B | ₩60.3B | ₩17.6B | ₩41.0B | ₩77.0B |
| Total equity | ₩119.4B | ₩129.6B | ₩137.7B | ₩115.7B | ₩121.0B |
| Paid-in capital | ₩40.7B | ₩53.5B | ₩76.9B | ₩82.4B | ₩85.9B |
| Debt/equity (source value) | 47.7% | 46.5% | 12.8% | 35.5% | 63.6% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2009-12-01
- Listed
- 09/12/30
- Employees
- 32
- Auditor
- 삼일회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1701110391532
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 메타케어Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.